Pilot Study About Tamoxifen Therapy for Breast Cancer Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by National Cancer Center, Korea
Sponsor:
Information provided by (Responsible Party):
Eun Sook Lee, National Cancer Center, Korea
ClinicalTrials.gov Identifier:
NCT02094495
First received: March 20, 2014
Last updated: June 24, 2014
Last verified: June 2014

March 20, 2014
June 24, 2014
June 2014
March 2017   (final data collection date for primary outcome measure)
The knowledge questionnaire about tamoxifen [ Time Frame: The study outcome measure will be assessed by face-to-face, one time. ] [ Designated as safety issue: No ]
There are no more follow up except one time
Same as current
Complete list of historical versions of study NCT02094495 on ClinicalTrials.gov Archive Site
Decision Conflict Scale [ Time Frame: The study outcome measure will be assessed by face-to-face , one time. ] [ Designated as safety issue: No ]
There are no more follow up except one time.
Same as current
  • 1. Satisfaction with Decision scale [ Time Frame: The study outcome measure will be assessed by face-to-face , one time. ] [ Designated as safety issue: No ]
    There are no more follow up except one time
  • Quality of life (EQ-5D, VAS) [ Time Frame: The study outcome measure will be assessed by face-to-face, one time. ] [ Designated as safety issue: No ]
  • Female Sexual Function Index - 6 items, Korean version [ Time Frame: The study outcome measure will be assessed by face-to-face, one time. ] [ Designated as safety issue: No ]
1. Satisfaction with Decision scale [ Time Frame: The study outcome measure will be assessed by face-to-face , one time. ] [ Designated as safety issue: No ]
There are no more follow up except one time
 
Pilot Study About Tamoxifen Therapy for Breast Cancer Patients
Pilot Study to Evaluate the Knowledge and Understanding on Tamoxifen Therapy for Breast Cancer Patients

The aim of this study are to to evaluate the knowledge and understanding on tamoxifen theraphy for breast cancer patients and examine the decision conflict scale and satisfaction with decision scale while making decision to take tamoxifen.

The knowlege questionnaire about tamoxifen was developed by the medication guides that provide for patients taking tamoxifen and hormone therapy for breast cancer fact sheet from National Cancaer Institute. Several experts in the field of breast cancer and gynecologic cancer are going to review and indicate the questionnaire.

Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

breast cancer patients who take tamoxifen at National Cancer Center

Breast Cancer
Not Provided
breast cancer group
Taking tamoxifen
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
300
March 2017
March 2017   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • The breast cancer patients who take tamoxifenExclusion Criteria:

Exclusion criteria

  • The patients who do not agree to participate in this study
  • The paitents who have trouble with understanding and reading Korean.
Female
18 Years and older
No
Contact: Eun Sook Lee, MD, PhD +82-31-920-2011 eslee@ncc.re.kr
Korea, Republic of
 
NCT02094495
NCC 2014-0112-0001
No
Eun Sook Lee, National Cancer Center, Korea
National Cancer Center, Korea
Not Provided
Principal Investigator: Eun Sook Lee, MD, PhD National Cancer Center, Korea
National Cancer Center, Korea
June 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP